Stockscreener 앱 받기
0.90
4.17%
-0.0392
전일 마감가:
$0.9392
열려 있는:
$0.9157
하루 거래량:
260.89K
Relative Volume:
0.40
시가총액:
$80.41M
수익:
-
순이익/손실:
$-166.14M
주가수익비율:
-0.4663
EPS:
-1.93
순현금흐름:
$-139.92M
1주 성능:
-23.73%
1개월 성능:
+5.47%
6개월 성능:
-37.06%
1년 성능:
-49.15%
1일 변동 폭
$0.90
$0.9393
1주일 범위
$0.90
$1.235
52주 변동 폭
$0.535
$3.405
Allakos Inc Stock (ALLK) Company Profile
명칭
Allakos Inc
전화
650-597-5002
주소
825 INDUSTRIAL ROAD, SAN CARLOS, CA
ALLK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ALLK | 0.90 | 80.41M | 0 | -166.14M | -139.92M | -1.93 |
| VRTX | 450.67 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.00 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.18 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.51 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.00 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Allakos Inc Stock (ALLK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-01-17 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-01-16 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-18 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-08 | 재개 | Jefferies | Buy |
| 2023-09-27 | 개시 | JMP Securities | Mkt Outperform |
| 2023-05-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-07 | 개시 | Piper Sandler | Overweight |
| 2022-09-12 | 다운그레이드 | SMBC Nikko | Neutral → Underperform |
| 2021-12-22 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-12-22 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-12-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-12-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-08-26 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-15 | 개시 | Cowen | Outperform |
| 2021-05-18 | 개시 | H.C. Wainwright | Buy |
| 2021-02-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 개시 | BofA Securities | Buy |
| 2020-12-21 | 개시 | SVB Leerink | Outperform |
| 2020-02-27 | 개시 | Barclays | Underweight |
| 2020-02-04 | 재개 | Goldman | Neutral |
| 2018-08-13 | 개시 | Goldman | Neutral |
| 2018-08-13 | 개시 | Jefferies | Buy |
| 2018-08-13 | 개시 | William Blair | Outperform |
모두보기
Allakos Inc 주식(ALLK)의 최신 뉴스
Allakos Reports Q3 2024 Results and Research Progress - TipRanks
All You Need to Know About Allakos (ALLK) Rating Upgrade to Buy - MSN
Allakos Inc. finalizes early lease termination, incurring $2.5 million in costs - Investing.com Canada
Allakos Inc. Alters Lease Agreement for Cost Savings - TipRanks
FMR LLC's Strategic Acquisition of Allakos Inc Shares - GuruFocus.com
Allakos's SWOT analysis: biotech firm's stock faces hurdles in CSU market - Investing.com
FY2024 EPS Estimates for Allakos Raised by Leerink Partnrs - MarketBeat
Allakos Runs Up Into A Near-Term Catalyst (NASDAQ:ALLK) - Seeking Alpha
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Allakos perks up after early-stage data for lead asset - MSN
Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Allakos Inc. (NASDAQ:ALLK) Short Interest Down 17.1% in October - MarketBeat
3 US Penny Stocks With Market Caps Larger Than $50M - Simply Wall St
Allakos Insiders Miss 24% Gain After Offloading Stock - Simply Wall St
Vernal Keratoconjunctivitis Market Growth to Accelerate - openPR
The Manufacturers Life Insurance Company Sells 2,148 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Short Interest in Custom Truck One Source, Inc. (NYSE:CTOS) Decreases By 5.5% - Defense World
Nasal Polyposis Market Size is Set for Rapid Growth as Innovative - openPR
Chronic Spontaneous Urticaria Market Forecasted to Surge - openPR
Jefferies downgrades Allakos Inc (ALLK) stock to a Hold - Knox Daily
Allakos Inc (ALLK)’s stock price range in the last year - US Post News
Investor’s Delight: Allakos Inc (ALLK) Closes Weak at 0.65, Down -1.14 - The Dwinnex
Allakos shares hold rating after trial update By Investing.com - Investing.com Australia
Piper Sandler maintains Overweight rating on Allakos shares By Investing.com - Investing.com Australia
TD Cowen Reiterates Hold Rating on Allakos Inc. (ALLK) - StreetInsider.com
Piper Sandler maintains Overweight rating on Allakos shares - Investing.com India
Allakos shares hold rating after trial update - Investing.com
Allakos stock gains on trial data for lead drug (NASDAQ:ALLK) - Seeking Alpha
Piper Sandler Reiterates Overweight Rating on Allakos Inc. (ALLK) - StreetInsider.com
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - ForexTV.com
Allakos reports positive results from AK006 Phase 1 study - Investing.com India
Allakos Progress Update on AK006 and Future Milestones - TipRanks
Allakos reports positive results from AK006 Phase 1 study By Investing.com - Investing.com UK
Allakos (ALLK) Reports Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers - StreetInsider.com
SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World
Vernal Keratoconjunctivitis Market to Show Remarkable Growth - openPR
Vernal Keratoconjunctivitis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Santen SAS, Novartis, Laboratoires Thea, Allakos Inc., Santen SASl, Astellas Pharma Inc - Barchart
Duff & Phelps Investment Management Co. Cuts Holdings in Enbridge Inc. (NYSE:ENB) - Defense World
Allakos (ALLK): Strong Industry, Solid Earnings Estimate Revisions - MSN
Wall Street SWOT: Allakos stock faces pivotal year as AK006 data looms - Investing.com
Allakos (NASDAQ:ALLK) Receives Market Outperform Rating from JMP Securities - MarketBeat
Leerink Partners analysts initates a Market perform rating for Align Technology, Inc. (ALGN) - Knox Daily
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
French InsurTech Alan raises $193m to bolster tech and growth in Belgium - FinTech Global
Allied Properties Real Estate Investment Trust (TSE:AP.UN) Price Target Increased to C$18.50 by Analysts at Canaccord Genuity Group - MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) Reaches New 52-Week Low at $8.28 - MarketBeat
Allogene Therapeutics Inc [ALLO] Stock bought by Insider Douglas Earl Martin for $78844.0 - Knox Daily
Alignment Healthcare (NASDAQ:ALHC) Shares Gap Down to $11.43 - Defense World
Investing in Alta Equipment Group Inc (ALTG): What You Must Know - Knox Daily
Allegion Stock: Is ALLE Outperforming The Industrials Sector? - Barchart
Allakos Inc (ALLK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):